Cumberland Pharmaceuticals (CPIX) Retained Earnings (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Retained Earnings of -$30.1 million for Q1 2026, down 12.27% sequentially from -$26.8 million in Q4 2025, and down 32.51% YoY from -$44.6 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Retained Earnings (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Retained Earnings for 17 years, with the latest figure at -$30.1 million in Q1 2026.
- Quarterly Retained Earnings fell 32.51% year-over-year to -$30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.1 million (down 32.51% YoY) and the FY2025 annual result came in at -$26.8 million, down 11.83% from the prior year.
- Retained Earnings fell to -$30.1 million in Q1 2026 per CPIX's latest filing, from -$26.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$7.0 million in Q1 2022 and troughed at -$30.1 million in Q1 2026.
- A 5-year average of -$17.6 million and a median of -$19.4 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings sank 1036.38% in 2022, then fell 11.83% in 2025.
- Over 5 years, Retained Earnings stood at -$11.2 million in 2022, then tumbled by 56.02% to -$17.5 million in 2023, then tumbled by 37.05% to -$24.0 million in 2024, then decreased by 11.83% to -$26.8 million in 2025, then declined by 12.27% to -$30.1 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$30.1 million, -$26.8 million, and -$25.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Cumberland Pharmaceuticals | 117.01 Mn | 113.14 Mn | - | -34.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.37 Mn |
| Mar 31, 2026 | -30.09 Mn |
| Dec 31, 2025 | -26.80 Mn |
| Sep 30, 2025 | -25.39 Mn |
| Jun 30, 2025 | -23.45 Mn |
| Mar 31, 2025 | -22.71 Mn |
| Dec 31, 2024 | -23.97 Mn |
| Sep 30, 2024 | -22.06 Mn |
| Jun 30, 2024 | -20.52 Mn |
| Mar 31, 2024 | -19.43 Mn |
| Dec 31, 2023 | -17.49 Mn |
| Sep 30, 2023 | -11.19 Mn |
| Jun 30, 2023 | -10.14 Mn |
| Mar 31, 2023 | -11.02 Mn |
| Dec 31, 2022 | -11.21 Mn |
| Sep 30, 2022 | -8.77 Mn |
| Jun 30, 2022 | -8.36 Mn |
| Mar 31, 2022 | -7.02 Mn |
| Dec 31, 2021 | -5.64 Mn |
| Sep 30, 2021 | -1.79 Mn |